14 Aug, EOD - Indian

Nifty IT 34833.2 (0.40)

Nifty Next 50 66511.6 (-0.17)

Nifty 50 24631.3 (0.05)

Nifty Midcap 100 56504.25 (-0.31)

Nifty Pharma 22151.85 (0.10)

Nifty Smallcap 100 17547.45 (-0.38)

SENSEX 80597.66 (0.07)

Nifty Bank 55341.85 (0.29)

14 Aug, EOD - Global

NIKKEI 225 42649.26 (-1.45)

HANG SENG 25519.32 (-0.37)

S&P 6486.12 (-0.02)

LOGIN HERE

companylogoIntegrated Proteins Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 519606 | NSE Symbol : | ISIN : INE177M01013 | Industry : Trading |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
08-Aug-2025 14-Aug-2025 Quarterly Results Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Prior Intimation of Board Meeting and Trading Window Regulation 29 (1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015
31-Jul-2025 07-Aug-2025 Conversion Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations 2015. Outcome of Board Meeting held today i.e., August 7, 2025 (As per BSE Announcement Dated on 07/08/2025)
01-Aug-2025 01-Aug-2025 Change in Other Executives Outcome of Board Meeting held today i.e., August 1, 2025
23-May-2025 28-May-2025 Accounts Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on March 31 2025 along with the Auditors Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. Audited Financial Results For the Quarter and Financial year ended March 31, 2025 (As Per BSE Announcement Dated on :28.05.2025)
15-May-2025 15-May-2025 Change in Other Executives Outcome of the meeting of the Board of Directors held on Thursday, May 15, 2025
01-Apr-2025 01-Apr-2025 Change in Other Executives Intimation of Appointment of Company Secretary and Compliance officer of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements )Regulations,2015
06-Mar-2025 05-Mar-2025 Change in Auditors Announcement under Regulation 30 of SEBI (LODR)Regulations ,2015 for appointment of Internal Auditor Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations ,2015 for appointment of Secretarial Auditor
21-Feb-2025 25-Feb-2025 Change in Auditors INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2025 inter alia to consider and approve 1) To consider and approve the Appointment of M/s B.B. Gusani and Associates Practicing Chartered Accountants (FRN : 140785W ) as Statutory Auditor of the Company to fill the casual vacancy arising from the resignation of previous Statutory Auditor i.e. DGMS and Co. subject to approval of the shareholders of the Company till the conclusion of the upcoming Annual General Meeting. 2) To appoint CS Ankita Tejas Shah Practising Company Secretary and Designated Partner of Vast & Co. Company Secretaries LLP as the Scrutinizer of the Company. 3) To approve and declare relevant date and to approve draft of Postal ballot notice. 1. Considered and approved the appointment of the M/s B.B. Gusani and Associates, Practicing Chartered Accountants (FRN:140785W ) as Statutory Auditor of the Company to fill the casual vacancy arising from the resignation of previous Statutory Auditor i.e. DGMS and Co. subject to the approval of the shareholders till the conclusion of the upcoming Annual General Meeting . The requisite details in compliance with Regulation 30 of the SEBI LODR Regulations, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024, are provided in Annexure-A. 2. Appointment of CS Ankita Tejas Shah, Practising Company Secretary and Designated Partner of Vast & Co. Company Secretaries LLP as the Scrutinizer of the General Meeting through Postal Ballot. 3. Approved the draft notice of the Postal Ballot. Announcement under Regulation 30-Appointment of Statutory Auditor to fill the casual Vacancy arising from the resignation of previous auditor (As per BSE Announcement Dated on 25/02/2025)
11-Feb-2025 14-Feb-2025 Quarterly Results INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results for the quarter ended on December 2024 together with the Limited Review Report for the said period Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and in continuation to our letter dated 11th February, 2025, we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Friday, 14th February, 2025, inter-alia, to consider and approve the following: 1. Considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2024 together with the Limited Review Report by the Auditors. The Board meeting commenced at 2:30 PM and ended at 4:00 P.M. You are requested to take above on your records. (As Per BSE Announcement Dated on 14.02.2025)
04-Feb-2025 04-Feb-2025 Preferential Issue Outcome of Meeting of the board of the director of the company held on February 04, 2025
03-Feb-2025 03-Feb-2025 Preferential Issue Outcome of Meeting of Board of Directors of the company held on February 03, 2025
01-Feb-2025 01-Feb-2025 Preferential Issue Outcome of the Meeting of Board of Directors of the Company held today i.e. February 01, 2025
28-Jan-2025 28-Jan-2025 Preferential Issue Allotment of 44,00,000 (Forty-Four Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees.
24-Jan-2025 24-Jan-2025 Preferential Issue Allotment of 20,00,000 (Twenty Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees.
10-Dec-2024 10-Dec-2024 Change in Auditors Outcome of Board Meeting held on Tuesday, 10th December, 2024
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +